Related Experiment Videos
Tie2 vascular endothelial receptor expression and function in hepatocellular carcinoma
Shinji Tanaka1, Keishi Sugimachi, Yo-ichi Yamashita Yi
1Department of Surgery and Science, Graduate School of Medical Sciences, and Station for Collaborative Research, Kyushu University, Fukuoka, Japan. shinjit@surg2.med.kyushu-u.ac.jp
Hepatology (Baltimore, Md.)
|March 27, 2002
Summary
The Tie2 receptor is overexpressed in hepatocellular carcinoma (HCC) tumors, promoting growth and neovascularization. Inhibiting the Angiopoietin/Tie2 pathway suppressed tumor progression in a mouse model, offering a potential treatment strategy.
Area of Science:
- Oncology
- Vascular Biology
- Molecular Medicine
Background:
- Hepatocellular carcinoma (HCC) is a hypervascular tumor with rapid growth.
- Angiopoietin (Ang) and its receptor Tie2 are implicated in tumor progression and angiogenesis.
- The specific role of Tie2 in hepatic oncogenesis remained largely unknown.
Purpose of the Study:
- To investigate the role of the Tie2 receptor in hepatocellular carcinoma (HCC) development and progression.
- To evaluate the therapeutic potential of inhibiting the Angiopoietin/Tie2 signaling pathway in HCC.
Main Methods:
- Immunohistochemical analysis of Tie2 receptor expression in human HCC tumors.
- In vitro studies using a soluble Tie2 ectodomain (sTie2) construct to assess Ang interaction and downstream effects.
- In vivo gene transfer of sTie2 in a murine HCC model to evaluate its impact on tumorigenicity and neovascularization.
Main Results:
- Tie2 receptor protein was overexpressed in 80% of human HCC tumors, correlating with cell dedifferentiation and tumor size.
- In vitro, sTie2 expression inhibited Ang protein interaction, Tie2 phosphorylation, and matrix metalloproteinase 9 (MMP-9) suppression.
- In vivo gene transfer of sTie2 suppressed tumorigenicity and neovascularization in a murine HCC model.
Conclusions:
- Tie2 receptor expression plays a significant role in HCC neovascularization and disease progression.
- Inhibition of the Angiopoietin/Tie2 signal transduction cascade represents a promising therapeutic strategy for HCC treatment.